NCT05933031View on ClinicalTrials.gov

Exploratory Study to Standard Triple Therapy With Tegoprazan(by Dose) in H. Pylori Positive Patients

PHASE2UnknownINTERVENTIONAL
Enrollment

381

Participants

Timeline

Start Date

February 27, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

Tegoprazan 50 mg Triple Therapy

Tegoprazan 50 mg/Clarithromycin/ Amoxicillin BID peroral, 14 days

DRUG

Tegoprazan 100 mg Triple Therapy

Tegoprazan 100 mg/Clarithromycin/ Amoxicillin BID peroral, 14 days

DRUG

Lansoprazole Triple Therapy

Lansoprazole/Clarithromycin/ Amoxicillin BID peroral, 14 days

Trial Locations (1)

Unknown

RECRUITING

Chung-Ang University Hosptial, Seoul

Sponsors
All Listed Sponsors
lead

HK inno.N Corporation

INDUSTRY